Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1992 May 15;146(10):1743–1746.

Revised guidelines on ethical and legal considerations in anonymous unlinked HIV seroprevalence research. Federal Centre for AIDS Working Group on Anonymous Unlinked HIV Seroprevalence Research.

PMCID: PMC1488684  PMID: 1596810

Full text

PDF
1743

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayer R., Lumey L. H., Wan L. The American, British and Dutch responses to unlinked anonymous HIV seroprevalence studies: an international comparison. AIDS. 1990 Apr;4(4):283–290. doi: 10.1097/00002030-199004000-00001. [DOI] [PubMed] [Google Scholar]
  2. Bayer R., Lumey L. H., Wan L. The American, British and Dutch responses to unlinked anonymous HIV seroprevalence studies: an international comparison. AIDS. 1990 Apr;4(4):283–290. doi: 10.1097/00002030-199004000-00001. [DOI] [PubMed] [Google Scholar]
  3. Gill O. N., Adler M. W., Day N. E. Monitoring the prevalence of HIV. BMJ. 1989 Nov 25;299(6711):1295–1298. doi: 10.1136/bmj.299.6711.1295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gill O. N., Adler M. W., Day N. E. Monitoring the prevalence of HIV. BMJ. 1989 Nov 25;299(6711):1295–1298. doi: 10.1136/bmj.299.6711.1295. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES